戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 nodeficiency virus 1, hepatitis C virus, and Japanese encephalitis virus.
2 milarities to the NS5 protein of the related Japanese encephalitis virus.
3  human pathogens, including dengue virus and Japanese encephalitis virus.
4 fever virus, dengue virus types 2 and 4, and Japanese encephalitis virus.
5 iruses including yellow fever, West Nile and Japanese encephalitis viruses.
6 an epidemic-causing dengue, yellow fever and Japanese encephalitis viruses.
7 patients: 216 (33%) of 664 cases were due to Japanese encephalitis virus, 27 (4%) were due to dengue
8 e, yellow fever, tick-borne encephalitis and Japanese encephalitis virus among many others.
9     Multiple known zoonotic viruses, such as Japanese encephalitis virus and mammalian orthoreovirus(
10 we found evidence of endemic transmission of Japanese encephalitis virus and recent outbreaks of deng
11 s of the flavivirus family: West Nile virus, Japanese encephalitis virus, and dengue virus 2.
12 yzed by related helicases from Dengue virus, Japanese encephalitis virus, and humans.
13  simplex virus, varicella zoster virus, HIV, Japanese encephalitis virus, and SARS-CoV-2, are linked
14  flaviviruses include dengue, West Nile, and Japanese encephalitis viruses, and the nonpathogenic fla
15 cryo-electron microscopy structure of mature Japanese encephalitis virus at near-atomic resolution, w
16 is are either preventable or treatable, with Japanese encephalitis virus being the most common cause.
17 es, assessed plasmid VRC5288 (Zika virus and Japanese encephalitis virus chimera), and the VRC 320, d
18                                In Australia, Japanese encephalitis virus circulated in tropical north
19 its divergence from the other members of the Japanese encephalitis virus complex, presumably in Afric
20 er (WNF), chikungunya, dengue, yellow fever, Japanese encephalitis virus, GBS, and control datasets.
21                   The global epidemiology of Japanese encephalitis virus has been further clarified.
22 easles, pertussis, meningococcal disease and Japanese encephalitis virus have been linked to lack of
23 lly include viral (for example, HIV, rabies, Japanese encephalitis virus, herpes simplex virus, varic
24  the neurovirulence and neuroinvasiveness of Japanese encephalitis virus in mice.
25 how reduced production of dengue virus-2 and Japanese encephalitis virus in these cells.
26 in critical for dengue hemorrhagic fever and Japanese encephalitis virus infection, inhibits NLRP3 in
27                                    Globally, Japanese encephalitis virus is the most important emergi
28 fferent flaviviruses may cause encephalitis, Japanese encephalitis virus is the most significant, bei
29 virus genus (including dengue, West Nile and Japanese encephalitis viruses) is regulated by a wide va
30 rresponding genes of an attenuated strain of Japanese encephalitis virus (JE), SA14-14-2.
31 ll eight live attenuated vaccines, including Japanese encephalitis virus (JEV) (SA-14-14-2), varicell
32                                     Although Japanese encephalitis virus (JEV) accounts for around 15
33  virus (TBEV), yellow fever virus (YFV), and Japanese encephalitis virus (JEV) and by comparing the r
34 y for the presumptive serodiagnosis of acute Japanese encephalitis virus (JEV) and West Nile virus (W
35        First, RC-101 robustly inhibited both Japanese encephalitis virus (JEV) and Zika virus (ZIKV)
36                            Four genotypes of Japanese encephalitis virus (JEV) are presently recogniz
37  dengue viruses (DENV), West Nile virus, and Japanese encephalitis virus (JEV) are widely used as ser
38                                        Using Japanese encephalitis virus (JEV) as a model, we perform
39                   A yellow fever virus (YFV)/Japanese encephalitis virus (JEV) chimera in which the s
40          In recent years, genotype I (GI) of Japanese encephalitis virus (JEV) has displaced genotype
41     However, the precise role of IRF8 during Japanese encephalitis virus (JEV) infection in the brain
42                                              Japanese encephalitis virus (JEV) invades the CNS, resul
43 terventions against neurotropic flaviviruses.Japanese encephalitis virus (JEV) is a Flavivirus respon
44                                              Japanese encephalitis virus (JEV) is a leading cause of
45                                              Japanese encephalitis virus (JEV) is a major threat to h
46                                              Japanese encephalitis virus (JEV) is a mosquito-borne zo
47                                              Japanese encephalitis virus (JEV) is a zoonotic, mosquit
48                                              Japanese encephalitis virus (JEV) is the leading global
49 ed vaccine candidates against newly emerging Japanese encephalitis virus (JEV) or Japanese encephalit
50 crophages in the brain, play a vital role in Japanese encephalitis virus (JEV) pathogenesis.
51                   Plasmid vectors containing Japanese encephalitis virus (JEV) premembrane (prM) and
52 e safety and efficacy of the live-attenuated Japanese encephalitis virus (JEV) SA14-14-2 vaccine are
53 tis virus (TBEV), West Nile virus (WNV), and Japanese encephalitis virus (JEV) that could complement
54 is is a mosquito-borne disease caused by the Japanese encephalitis virus (JEV) that is prevalent in A
55 , immunogenicity, and protective efficacy of Japanese encephalitis virus (JEV) virus-like particles (
56                                              Japanese encephalitis virus (JEV), a mosquito-borne flav
57                                              Japanese encephalitis virus (JEV), a mosquito-borne flav
58                                              Japanese encephalitis virus (JEV), although confined to
59 viviruses, such as West Nile virus (WNV) and Japanese encephalitis virus (JEV), POWV disease presenta
60 containing EIIIs from Koutango virus (KOUV), Japanese encephalitis virus (JEV), St. Louis encephaliti
61 s have routine vaccination campaigns against Japanese encephalitis virus (JEV), the effect of JEV imm
62 cation of three flaviviruses, DENV, WNV, and Japanese encephalitis virus (JEV), using a high-content
63                                 We diagnosed Japanese encephalitis virus (JEV), using antibody detect
64 ENV-1 to DENV-4), West Nile virus (WNV), and Japanese encephalitis virus (JEV), were constructed.
65 c amplification of yellow fever virus (YFV), Japanese encephalitis virus (JEV), West Nile virus (WNV)
66                                              Japanese encephalitis virus (JEV)-specific Fab antibodie
67 e zoonotic, mosquito-borne disease caused by Japanese encephalitis virus (JEV).
68 le virus (WNV), hepatitis C virus (HCV), and Japanese encephalitis virus (JEV).
69  dengue virus (DENV), Zika virus (ZIKV), and Japanese encephalitis virus (JEV).
70  dengue virus (DENV), Zika virus (ZIKV), and Japanese encephalitis virus (JEV).
71 dengue virus (DENV; nine isolates analyzed), Japanese encephalitis virus (JEV; one isolate analyzed)
72                    Louis encephalitis virus, Japanese encephalitis virus, Kunjin virus, Murray Valley
73  DENV NS1 with the corresponding region from Japanese encephalitis virus NS1 to create chimeric DJ NS
74 ve epitopes with the corresponding region of Japanese encephalitis virus NS1 to generate a chimeric D
75      The presence of dengue virus (DENV) and Japanese encephalitis virus NS1s in the blood of infecte
76 erminants of neurovirulence and stability in Japanese encephalitis virus, opening up new avenues for
77                         Recent work suggests Japanese encephalitis virus originated in the Indonesia-
78 ovirus, metapneumovirus, yellow fever virus, Japanese encephalitis virus, parainfluenza virus and Sen
79 eronegative individuals were seropositive to Japanese encephalitis virus prior to their infection).
80 tick-borne encephalitis virus serogroup) and Japanese encephalitis virus use the nonstructural protei
81              In addition to the plasmids for Japanese encephalitis virus, West Nile virus (WNV), St.
82 ated also with epidemics, required RelA, and Japanese encephalitis virus, which produced relatively m
83  (63.6%) were seropositive for Zika virus or Japanese encephalitis virus with FRNT.
84  were vaccinated with yellow fever, chimeric Japanese encephalitis virus (YF/JE), or chimeric West Ni